These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6071154)

  • 1. Blood coagulation, fibrinolysis, and contraceptive hormones.
    Brakman P; Albrechtsen OK; Astrup T
    JAMA; 1967 Jan; 199(2):69-74. PubMed ID: 6071154
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of changes in activity of some hemocoagulation factors during contraception and therapy with combinations of synthetic steroids with varied gestagenic components].
    Misinger I; Hermanská Z
    Cas Lek Cesk; 1971 Feb; 110(9):196-9. PubMed ID: 5547223
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of oral contraceptive estrogen on blood coagulation and fibrinolysis.
    Hedlin AM
    Thromb Diath Haemorrh; 1975 Apr; 33(2):370-8. PubMed ID: 1138426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation studies of menopausal women taking estrogen replacement.
    Beller FK; Nachtigall L; Rosenberg M
    Obstet Gynecol; 1972 May; 39(5):775-8. PubMed ID: 4260072
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of sex hormones on fibrinolytic phenomena].
    Zinelli G; Dallavalle L; Debiasi D
    Minerva Ginecol; 1968 Oct; 20(19):1590-5. PubMed ID: 5740789
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of lactation suppressants on the coagulation mechanism.
    Wodzicki AM; Coopland AT
    Can Med Assoc J; 1974 Apr; 110(8):905-9. PubMed ID: 4824964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestational agents and blood coagulation. II.
    Ambrus JL; Niswander KR; Courey NG; Wamsteker EF; Mink IB
    Am J Obstet Gynecol; 1969 Apr; 103(7):994-1001. PubMed ID: 5774681
    [No Abstract]   [Full Text] [Related]  

  • 8. [Side effects of the oral contraceptive Ovosiston on the blood coagulation system].
    Carol W; Klinger G; Hempel E; Starker K; Quent P
    Zentralbl Gynakol; 1970 Dec; 92(50):1641-50. PubMed ID: 4099364
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of different regimens of oestrogens on the clotting and fibrinolytic system of the post-menopausal woman.
    Thom M; Dubiel M; Kakkar VV; Studd JW
    Front Horm Res; 1977; 5():192-202. PubMed ID: 208880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolytic enhancement by stanozolol: a double blind trial.
    Davidson JF; Lochhead M; McDonald GA; McNicol GP
    Br J Haematol; 1972 May; 22(5):543-59. PubMed ID: 4555715
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of steroids, acetylsalicylic acid and bishydroxycoumarin on prothrombin time.
    Zawidzka Z; Coldwell BB
    Eur J Toxicol; 1971; 4(3):199-204. PubMed ID: 4106764
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of norethisterone on coagulation and fibrinolysis in Asian women.
    Tsakok FH; Koh S; Chua SE; Ratnam SS; Tyler CW; Layde P; Evatt BL
    Singapore Med J; 1984 Dec; 25(6):442-8. PubMed ID: 6531703
    [No Abstract]   [Full Text] [Related]  

  • 13. Oestrogenic treatment of prostatic cancer lowers the fibrinolytic activity in vein walls.
    Carlsson S; Astedt B
    Scand J Urol Nephrol; 1974; 8(3):169-72. PubMed ID: 4139751
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
    Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
    J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural oestrogen in the female climacteric--influence on blood coagulation and fibrinolysis.
    Lagrelius A; Lunell NO; Blombäck M
    Thromb Haemost; 1979 Feb; 40(3):532-41. PubMed ID: 154749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Estrogens, gestagens and lipid metabolism].
    Lauritzen C
    Z Ernahrungswiss Suppl; 1972; 12():Suppl 12:22-31. PubMed ID: 4505204
    [No Abstract]   [Full Text] [Related]  

  • 17. The levels of free and conjugated 17-hydroxycorticosteroids (17-OHCS) in theplasma of users of oral contraceptives.
    Pekkarinen A; Ulkkinen MO
    Ann Chir Gynaecol Fenn; 1969; 58(2):105-11. PubMed ID: 5363956
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of synthetic gestagens on fibrinolytic phenomenon].
    Terao T
    Nihon Sanka Fujinka Gakkai Zasshi; 1967 Nov; 19(11):1323-31. PubMed ID: 5626797
    [No Abstract]   [Full Text] [Related]  

  • 20. Progestational agents and blood coagulation. VI. Relationship of ABO blood types to changes induced by oral contraceptives.
    Lillie MA; Mink IB
    Am J Obstet Gynecol; 1974 Jun; 119(3):406-10. PubMed ID: 4827381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.